201 related articles for article (PubMed ID: 38233929)
1. Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization.
Boon K; Vanalken N; Szpakowska M; Chevigné A; Schols D; Van Loy T
Cell Commun Signal; 2024 Jan; 22(1):43. PubMed ID: 38233929
[TBL] [Abstract][Full Text] [Related]
2. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
3. How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.
Rajarathnam K; Schnoor M; Richardson RM; Rajagopal S
Cell Signal; 2019 Feb; 54():69-80. PubMed ID: 30465827
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.
Vacchini A; Mortier A; Proost P; Locati M; Metzemaekers M; Borroni EM
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486423
[TBL] [Abstract][Full Text] [Related]
5. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
6. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling.
Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A
Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.
Korbecki J; Bosiacki M; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686093
[TBL] [Abstract][Full Text] [Related]
8. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil recruitment by chemokines Cxcl1/KC and Cxcl2/MIP2: Role of Cxcr2 activation and glycosaminoglycan interactions.
Sawant KV; Sepuru KM; Lowry E; Penaranda B; Frevert CW; Garofalo RP; Rajarathnam K
J Leukoc Biol; 2021 Apr; 109(4):777-791. PubMed ID: 32881070
[TBL] [Abstract][Full Text] [Related]
10. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
Russo RC; Garcia CC; Teixeira MM; Amaral FA
Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
[TBL] [Abstract][Full Text] [Related]
11. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.
Moussouras NA; Getschman AE; Lackner ER; Veldkamp CT; Dwinell MB; Volkman BF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869519
[TBL] [Abstract][Full Text] [Related]
12. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
[TBL] [Abstract][Full Text] [Related]
13. Biased agonism as a mechanism for differential signaling by chemokine receptors.
Rajagopal S; Bassoni DL; Campbell JJ; Gerard NP; Gerard C; Wehrman TS
J Biol Chem; 2013 Dec; 288(49):35039-48. PubMed ID: 24145037
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
[TBL] [Abstract][Full Text] [Related]
15. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
[TBL] [Abstract][Full Text] [Related]
16. The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist.
Berg C; Wedemeyer MJ; Melynis M; Schlimgen RR; Hansen LH; Våbenø J; Peterson FC; Volkman BF; Rosenkilde MM; Lüttichau HR
PLoS Pathog; 2022 Mar; 18(3):e1010355. PubMed ID: 35271688
[TBL] [Abstract][Full Text] [Related]
17. The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.
Lüttichau HR
J Biol Chem; 2010 Mar; 285(12):9137-46. PubMed ID: 20044480
[TBL] [Abstract][Full Text] [Related]
18. Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer.
Mustafa S; See HB; Seeber RM; Armstrong SP; White CW; Ventura S; Ayoub MA; Pfleger KD
J Biol Chem; 2012 Apr; 287(16):12952-65. PubMed ID: 22371491
[TBL] [Abstract][Full Text] [Related]
19. Biophysical characterization of the CXC chemokine receptor 2 ligands.
Martin P; Kurth EA; Budean D; Momplaisir N; Qu E; Simien JM; Orellana GE; Brautigam CA; Smrcka AV; Haglund E
PLoS One; 2024; 19(4):e0298418. PubMed ID: 38625857
[TBL] [Abstract][Full Text] [Related]
20. Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.
Su Y; Raghuwanshi SK; Yu Y; Nanney LB; Richardson RM; Richmond A
J Immunol; 2005 Oct; 175(8):5396-402. PubMed ID: 16210646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
